191 related articles for article (PubMed ID: 8915786)
1. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia.
Halton JM; Atkinson SA; Fraher L; Webber C; Gill GJ; Dawson S; Barr RD
J Bone Miner Res; 1996 Nov; 11(11):1774-83. PubMed ID: 8915786
[TBL] [Abstract][Full Text] [Related]
2. Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: influence of disease, drugs and nutrition.
Atkinson SA; Halton JM; Bradley C; Wu B; Barr RD
Int J Cancer Suppl; 1998; 11():35-9. PubMed ID: 9876475
[TBL] [Abstract][Full Text] [Related]
3. Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukemia.
Halton JM; Atkinson SA; Fraher L; Webber CE; Cockshott WP; Tam C; Barr RD
J Pediatr; 1995 Apr; 126(4):557-64. PubMed ID: 7699533
[TBL] [Abstract][Full Text] [Related]
4. Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia.
Atkinson SA; Fraher L; Gundberg CM; Andrew M; Pai M; Barr RD
J Pediatr; 1989 May; 114(5):793-800. PubMed ID: 2785592
[TBL] [Abstract][Full Text] [Related]
5. Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study.
Wiernikowski JT; Barr RD; Webber C; Guo CY; Wright M; Atkinson SA
J Oncol Pharm Pract; 2005 Jun; 11(2):51-6. PubMed ID: 16460605
[TBL] [Abstract][Full Text] [Related]
6. Predictors of bony morbidity in children with acute lymphoblastic leukemia.
Rayar MS; Nayiager T; Webber CE; Barr RD; Athale UH
Pediatr Blood Cancer; 2012 Jul; 59(1):77-82. PubMed ID: 22190454
[TBL] [Abstract][Full Text] [Related]
7. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
8. Skeletal morbidity in children receiving chemotherapy for acute lymphoblastic leukemia and its association with mineral homeostasis and duration of inpatient stay.
Elmantaser ME; Young D; Gibson B; Ahmed SF
J Pediatr Hematol Oncol; 2011 Oct; 33(7):516-20. PubMed ID: 21941144
[TBL] [Abstract][Full Text] [Related]
9. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia.
van der Sluis IM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
J Pediatr; 2002 Aug; 141(2):204-10. PubMed ID: 12183715
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocol.
te Winkel ML; Pieters R; Hop WC; Roos JC; Bökkerink JP; Leeuw JA; Bruin MC; Kollen WJ; Veerman AJ; de Groot-Kruseman HA; van der Sluis IM; van den Heuvel-Eibrink MM
Bone; 2014 Feb; 59():223-8. PubMed ID: 24287213
[TBL] [Abstract][Full Text] [Related]
11. Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: a 1-year prospective study.
Arikoski P; Komulainen J; Riikonen P; Voutilainen R; Knip M; Kröger H
J Clin Endocrinol Metab; 1999 Sep; 84(9):3174-81. PubMed ID: 10487683
[TBL] [Abstract][Full Text] [Related]
12. Hypomagnesemia associated with chemotherapy in patients treated for acute lymphoblastic leukemia: possible mechanisms.
Guo CY; Halton JM; Barr RD; Atkinson SA
Oncol Rep; 2004 Jan; 11(1):185-9. PubMed ID: 14654924
[TBL] [Abstract][Full Text] [Related]
13. Relative osteopenia after treatment for acute lymphoblastic leukemia.
Warner JT; Evans WD; Webb DK; Bell W; Gregory JW
Pediatr Res; 1999 Apr; 45(4 Pt 1):544-51. PubMed ID: 10203147
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of bone metabolism in children with acute lymphoblastic leukemia after induction chemotherapy treatment.
Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Koliouskas D; Papastergiou C; Tsituridis I
Pediatr Hematol Oncol; 2005 Jun; 22(4):285-9. PubMed ID: 16020115
[TBL] [Abstract][Full Text] [Related]
15. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood.
Brennan BM; Rahim A; Adams JA; Eden OB; Shalet SM
Br J Cancer; 1999 Apr; 79(11-12):1859-63. PubMed ID: 10206305
[TBL] [Abstract][Full Text] [Related]
16. Bone mass and bone mineral metabolism at diagnosis and after intensive treatment in children with acute lymphoblastic leukemia.
Swiatkiewicz V; Wysocki M; Odrowaz-Sypniewska G; Koltan A; Manysiak S; Dylewska K
Med Pediatr Oncol; 2003 Dec; 41(6):578-80. PubMed ID: 14595724
[No Abstract] [Full Text] [Related]
17. Bone mass after treatment for acute lymphoblastic leukemia in childhood.
Nysom K; Holm K; Michaelsen KF; Hertz H; Müller J; Mølgaard C
J Clin Oncol; 1998 Dec; 16(12):3752-60. PubMed ID: 9850018
[TBL] [Abstract][Full Text] [Related]
18. Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database.
Högler W; Wehl G; van Staa T; Meister B; Klein-Franke A; Kropshofer G
Pediatr Blood Cancer; 2007 Jan; 48(1):21-7. PubMed ID: 16317756
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonate therapy for reduced bone mineral density during treatment of acute lymphoblastic leukemia in childhood and adolescence: a report of preliminary experience.
Lethaby C; Wiernikowski J; Sala A; Naronha M; Webber C; Barr RD
J Pediatr Hematol Oncol; 2007 Sep; 29(9):613-6. PubMed ID: 17805035
[TBL] [Abstract][Full Text] [Related]
20. Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia.
den Hoed MA; Pluijm SM; te Winkel ML; de Groot-Kruseman HA; Fiocco M; Hoogerbrugge P; Leeuw JA; Bruin MC; van der Sluis IM; Bresters D; Lequin MH; Roos JC; Veerman AJ; Pieters R; van den Heuvel-Eibrink MM
Haematologica; 2015 Dec; 100(12):1564-70. PubMed ID: 26405155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
